How EKF Diagnostics is taking personalized medicine from cancer to diabetes
This article was originally published in Clinica
Executive Summary
Personalized medicine has long been a buzz phrase in oncology, and it is fair to say that this sector has seen the biggest advances in biomarkers so far. But the strategy, which involves using genetic or other markers to identify patients likely (or not) to respond to a particular treatment, could also have applications in other fields.